knowledge -WSS

knowledge

author：knowledge 2025-09-29 18:18:01 - browse：528

On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a protein’s structure from its amino acid sequence, leapfrogging other approaches in computational biology.

Now, the companies say they have developed the model to predict not just standalone protein structures, but what proteins look like in combination with several classes of molecules, including small molecules and nucleic acids — capabilities that are key for drug development.

“We really needed to make progress on protein-ligand binding and co-folding of ligands with proteins in order to help us design more effective drugs,” said Demis Hassabis, CEO of both DeepMind and Isomorphic Labs, which spun out in 2021 with the goal of applying deep learning approaches to drug discovery. The updated model can also predict protein structures after they’ve been modified. “Basically the new AlphaFold can cope with all of these different things, which is pretty amazing.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Biotech reporter’s notebook: A sunnier mood at JPM 2024

focus

WSS

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Medicare Advantage enrollment grows 7.1% to 33.4 million people

FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

Wikipedia

knowledge

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Heart disease and mental health: A look at cardiac psychology

Novavax promises a turnaround & Lilly roils the obesity market

Weight loss drugs aren’t covered by Obamacare. That may change

Sports medicine is finally prioritizing gender equality

Ukraine seeks to reclaim its role as a hub for clinical trials

Heart attack and stroke risk calculators need revising

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

Trump demands the U.S. pay no more for drugs than other countries … again

Generative AI mines health records to identify patients’ social needs

hotspot

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

JPM 2024: Nvidia claims we're in biological revolution. Are we?

Abridge raises $150m as clinical notes automation market heats up

New study raises questions about niacin and heart health

Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

New Medicare drug pricing powers could soon be upended in court

hotspot

focus

Wikipedia

hotspot